Sony Corporation reported its strongest second-quarter operating income a 16% increase against the same period last year, which was attributed to its robust image sensor sales. The second-quarter results have raised Sony’s full-year earnings outlook.
As at 30th September 2019, operating income for quarter 2 (Q2) 2019 was $2.59 billion up 16% from $2.23 billion in Q2 2018. The consolidated operating income forecast for the full-year is expected to increase by $278 million to $7.78 billion from an earlier estimate of $7.5 billion.
Income drivers
Meanwhile, the sales and operating revenue for Q2 2019 recorded a slight decline of 3%, amounting to $19.76 billion against $20.32 billion from the same period last year.
The significant increase was mostly driven by growth in operating income in the imaging and sensing solutions segment to the tune of 59% to $711 million, while it reported a 22% rise in sales to $2.89 billion.
With the growth of multi-camera set-ups, Sony is providing smartphone manufacturers with imaging sensors for their products that primarily contributed to an increase in unit sales and improvement in product mix, resulting in better second-quarter results.
“In the Middle East & Africa region, we are confidently moving into the yearend peak sales season with a solid array of industry-leading products in the digital imaging, television and audio products categories,” said Mr Takakiyo Fujita, Managing Director, Sony Middle East and Africa.
The introduction of powerful full-frame mirrorless cameras α9II and α7RIV as well as the compact RX100 VII has helped Sony retain leadership in the high-end of the camera market. BRAVIA 8K LED TVs and new range of OLED TVs lead new product introductions in the very competitive televisions market, mr Fujita said.
More products click in
“ The much-acclaimed truly wireless WF-1000XM3 noise cancelling earbuds continue to show very strong demand. With these product offerings, I am certain we will finish the year on a very strong note,” he said.
Meanwhile, the Electronics Products & Solutions (EP&S) segment also recorded an increase of 151% year-on-year to $385.5 million compared to the previous period of $153.6 million.
Next Read >> A Look at ‘Kenya’s Best’ Cancer Treatment Machine
